Serial Body Composition Measurements by PEAPOD
NCT07926620, Not yet recruiting, Shoklo Malaria Research Unit
Trial 9
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
| Field | Value | Source |
|---|---|---|
| Title | Serial Body Composition Measurements by PEAPOD | ClinicalTrials.gov |
| NCT number | NCT07926620 | ClinicalTrials.gov |
| Status | Not yet recruiting | ClinicalTrials.gov |
| Enrollment | 300 participants, estimated | ClinicalTrials.gov |
| Lead sponsor | Shoklo Malaria Research Unit | ClinicalTrials.gov |
| Conditions | Infant, Small for Gestational Age, Body Composition, Infant Growth | ClinicalTrials.gov |
| Interventions | PEAPOD Air Displacement Plethysmography Device | ClinicalTrials.gov |
| First posted | 2026-11-09 | ClinicalTrials.gov |
| Last updated | 2026-11-09 | ClinicalTrials.gov |
Registered outcomes 11
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description | Source |
|---|---|---|---|---|
| Primary | Body composition changes - Fat mass in neonates with small for gestational age (SGA) and appropriate for gestational age (AGA) at birth and during the first 6 months of life | At birth, 1, 2, 3, 4, 5 and 6 months of life (unless body weight >6.0kg is reached first) | Fat mass (kg) measured using air displacement plethysmography (PEAPOD) at birth and during follow-up visits to compare between small for gestational age (SGA) and appropriate for gestational age (AGA) infants | ClinicalTrials.gov |
| Primary | Body composition changes - Fat-free mass in neonates with small for gestational age (SGA) and appropriate for gestational age (AGA) at birth and during the first 6 months of life | At birth, 1, 2, 3, 4, 5 and 6 months of life (unless body weight >6.0kg is reached first) | Fat-free mass (kg) measured using PEAPOD at birth and during follow-up visits to compare between SGA and AGA infants | ClinicalTrials.gov |
| Primary | Percentage body fat in SGA and AGA infants | At birth, 1, 2, 3, 4, 5 and 6 months of life (unless body weight >6.0kg is reached first) | Percentage body fat (%) measured using PEAPOD at birth and during follow-up visits to compare between SGA and AGA infants | ClinicalTrials.gov |
| Secondary | Maternal First-Trimester Body Mass Index (BMI) | Baseline (antenatal records) | Maternal first-trimester BMI (kg/m²) calculated from weight and height recorded during antenatal care | ClinicalTrials.gov |
| Secondary | Maternal Gestational Weight Gain | Baseline (antenatal records) | Maternal gestational weight gain (kg) calculated from antenatal weight measurements | ClinicalTrials.gov |
| Secondary | Gestational Diabetes Mellitus Status | Baseline (antenatal records) | Presence or absence of gestational diabetes mellitus documented in maternal clinical records | ClinicalTrials.gov |
| Secondary | Maternal Anaemia | Baseline to maximum 6 months postpartum | Presence or absence of maternal anaemia determined from maternal haemoglobin measurements | ClinicalTrials.gov |
| Secondary | Maternal HbA1c Concentration | Delivery and 2 months postpartum | Maternal glycated haemoglobin (HbA1c) percentage (%) measured from maternal blood samples | ClinicalTrials.gov |
| Secondary | Breast Milk Creamatocrit | At birth to maximum 6 months postpartum | Creamatocrit percentage (%) measured from maternal breast milk samples | ClinicalTrials.gov |
| Secondary | Breast Milk Sodium Concentration | At birth to maximum 6 months postpartum | Sodium concentration (mmol/L) measured from maternal breast milk samples | ClinicalTrials.gov |
| Secondary | Breast Milk Proteomic Profile | Delivery and monthly postpartum until 6 months | Proteomic profile of maternal breast milk measured using MALDI-TOF analysis | ClinicalTrials.gov |
Outcomes 0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as | Source |
|---|
Results by group 0
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units | Source |
|---|
Participant flow 0
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted | Source |
|---|
Adverse events 0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events | Source |
|---|
Adverse event totals 0
The totals the trial posted for each group.
| Total | Group | Affected | At risk | Source |
|---|
Papers 0
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as | Source |
|---|
Grants 0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years | Source |
|---|
Trial comparisons 0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|
Tests 0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|
Source 5
| Field | Value | Source |
|---|---|---|
| Release | trials-2026-11-12-0.4.0 | ClinicalTrials.gov |
| Release manifest SHA-256 | 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4 | ClinicalTrials.gov |
| Registry capture | 2026-11-12 | ClinicalTrials.gov |
| Results copy, AACT | 2026-03-23 | ClinicalTrials.gov |
| NIH clinical studies file | 2026-11-13 | ClinicalTrials.gov |
Release trials-2026-11-12-0.4.0
ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
NIH RePORTER's clinical studies and project files: Public domain (NIH RePORTER)